Management of Bacterial Vaginosis After Sacrocolpopexy
Treat bacterial vaginosis after sacrocolpopexy with oral metronidazole 500 mg twice daily for 7 days, as BV following invasive gynecologic procedures significantly increases the risk of serious post-operative infections including vaginal cuff cellulitis and pelvic abscess.
Rationale for Treatment
The evidence strongly supports treating BV in the post-operative setting, particularly after procedures involving mesh or graft material like sacrocolpopexy. BV-associated bacteria have been recovered from the endometrium and salpinges of women with pelvic inflammatory disease, and BV is directly associated with vaginal cuff cellulitis, pelvic cellulitis, and pelvic abscess following invasive gynecologic procedures 1. Given that sacrocolpopexy involves mesh placement and is classified as a clean-contaminated procedure, the presence of BV creates substantial risk for surgical site infection.
Recent research confirms that BV increases the risk of post-hysterectomy infections and other gynecological surgical complications 2, 3. While the guidelines don't specifically address sacrocolpopexy, they clearly establish that BV treatment reduces post-operative pelvic infections following invasive procedures 1.
Treatment Regimen
First-Line Therapy
- Metronidazole 500 mg orally twice daily for 7 days 1
- Advise patient to avoid alcohol during treatment and for 24 hours after completion
- This regimen achieves 95% cure rates 1
Alternative Regimens (if oral metronidazole not tolerated)
- Clindamycin 300 mg orally twice daily for 7 days 1
- Metronidazole gel 0.75%, one full applicator intravaginally twice daily for 5 days 1
- Clindamycin cream 2%, one full applicator intravaginally at bedtime for 7 days 1
Note: The single-dose metronidazole 2g regimen has lower efficacy (84% vs 95%) and should be avoided in the post-operative setting where complete eradication is critical 1.
Clinical Considerations
Why Oral Therapy is Preferred Post-Operatively
While intravaginal preparations minimize systemic side effects, oral metronidazole provides superior tissue penetration and is preferred when there's concern for deeper pelvic infection or when mesh/graft material is present 1. The 7-day oral regimen achieves the highest cure rates and is most appropriate given the serious consequences of treatment failure after sacrocolpopexy.
Diagnostic Confirmation
Before treating, confirm BV diagnosis using clinical criteria (need 3 of 4):
- Homogeneous white discharge coating vaginal walls
- Clue cells on microscopy
- Vaginal pH > 4.5
- Positive whiff test (fishy odor with KOH) 1
Do not culture for Gardnerella vaginalis - it lacks specificity as it's present in 50% of normal women 1.
Common Pitfalls to Avoid
- Don't use single-dose metronidazole - the 84% cure rate is insufficient in the post-operative setting where mesh is present
- Don't delay treatment - BV-associated organisms can rapidly cause vaginal cuff cellulitis and pelvic infections after invasive procedures 1
- Don't treat asymptomatic partners - partner treatment doesn't reduce recurrence rates in standard cases 1 (though recent evidence suggests benefit in recurrent BV 4)
- Don't assume intravaginal therapy is equivalent - while effective for uncomplicated BV, oral therapy provides better systemic coverage when surgical complications are a concern
Follow-Up
Follow-up is only necessary if symptoms persist 1. If treatment fails, consider:
- Retreatment with the same 7-day regimen
- Alternative diagnosis (candidiasis, trichomoniasis, surgical site infection)
- Evaluation for mesh complications or deeper pelvic infection
Recurrence is common (>50% within 6 months) 5, 6, but this reflects the natural history of BV rather than treatment failure in the immediate post-operative period.